Stevanato Group S.p.A. (STVN) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

26.4x

EV/EBITDA

19.0x

Market Cap

$5.59B

MomentumView details →

1D Return

−0.34%

YTD Return

+1.99%

RSI (14)

45.2

ValuationView details →

P/E (Fwd)

26.4x

EV/EBITDA

19.0x

Market Cap

$5.59B

RSI (14)

45.2

MomentumView details →

1D Return

−0.34%

YTD Return

+1.99%

SummaryUpdated Jun 1, 2026

Stevanato Group S.p.A. (NYSE:STVN) is an Italian pharmaceutical packaging and equipment company founded in 1949 and headquartered in Piombino Dese, Italy. The company went public in July 2021 and operates as a subsidiary of Stevanato Holding S.R.L. Stevanato has evolved from a traditional glass manufacturer into a leading provider of integrated solutions for the pharmaceutical and healthcare industries, specializing in drug containment, delivery systems, and manufacturing equipment. The company serves global pharmaceutical companies through manufacturing facilities in Italy, the United States, and other international locations.

Ask drillr about Stevanato Group S.p.A. →

ProfitabilityView details →

Gross Margin

29.16%

Net Margin

10.99%

EBITDA Margin

22.25%

ROE (TTM)

8.66%

ROA (TTM)

5.13%

Asset Turnover

0.47x

GrowthView details →

Revenue YoY

+6.72%

EPS YoY

−4.00%

FCF YoY

+82.06%

Revenue CAGR 3Y

+5.02%

EPS CAGR 3Y

−2.58%

EBITDA YoY

−12.32%

EarningsView details →

EPS (Actual)

$0.16

EPS Surprise

10.50%

Beats (12Q)

7/12

Next Q EPS Est

$0.18

Avg Surprise (4Q)

9.53%

Rev Surprise

1.27%

Capital & dividendView details →

Debt/Equity

0.29x

Current Ratio

1.61x

Quick Ratio

1.08x

Div Yield

0.30%

Div Rate

$0.06

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.22B

Net Income (TTM)

134.25M

Op. CF (TTM)

247.03M

Next earningsNov 5, 2026 →

Latest newsMore news →

Stevanato Group divested its California-based subsidiary Balda C. Brewer, and updated its full-year outlook to reflect this divestiture.26d ago

Stevanato Group reported an 8% increase in revenue to €302.0 million for the second quarter of 2026, with high-value solutions representing 45% of total revenue.31d ago

Similar companies

Shanghai Kindly Medical Instruments Co., Ltd.01501.HK Teleflex IncorporatedTFX Merit Medical Systems, Inc.MMSI Bausch + Lomb CorporationBLCO Haemonetics CorporationHAE 天智航-U688277.SH Find similar companies →

Latest newsMore news →

Stevanato Group divested its California-based subsidiary Balda C. Brewer, and updated its full-year outlook to reflect this divestiture.26d ago Stevanato Group reported an 8% increase in revenue to €302.0 million for the second quarter of 2026, with high-value solutions representing 45% of total revenue.31d ago Stevanato Group announced that liraglutide combination products using its Alina pen injector received marketing authorizations in multiple European countries.36d ago